These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 33720693)
1. Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia. Ribera J; Vilches C; Sanz V; de Miguel I; Portolés I; Córdoba-Jover B; Prat E; Nunes V; Jiménez W; Quidant R; Morales-Ruiz M ACS Nano; 2021 Apr; 15(4):7547-7562. PubMed ID: 33720693 [TBL] [Abstract][Full Text] [Related]
2. Artificial MicroRNA-Mediated Tgfbr2 and Pdgfrb Co-Silencing Ameliorates Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice. Jiang Y; Zhao Y; He F; Wang H Hum Gene Ther; 2019 Feb; 30(2):179-196. PubMed ID: 30024280 [TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor receptor β-targeted positron emission tomography imaging for the noninvasive monitoring of liver fibrosis. Li Z; Yang H; Li X; She T; Tao Z; Zhong Y; Su T; Feng Y; Shi Q; Li L; Tian R; Wang S; Cheng J; Cai H; Lu X Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1530-1543. PubMed ID: 38189910 [TBL] [Abstract][Full Text] [Related]
4. PDGFRβ-targeted TRAIL specifically induces apoptosis of activated hepatic stellate cells and ameliorates liver fibrosis. Li R; Li Z; Feng Y; Yang H; Shi Q; Tao Z; Cheng J; Lu X Apoptosis; 2020 Feb; 25(1-2):105-119. PubMed ID: 31894448 [TBL] [Abstract][Full Text] [Related]
5. Cellular crosstalk mediated by platelet-derived growth factor BB and transforming growth factor β during hepatic injury activates hepatic stellate cells. Mekala S; Tulimilli SV; Geesala R; Manupati K; Dhoke NR; Das A Can J Physiol Pharmacol; 2018 Aug; 96(8):728-741. PubMed ID: 29558627 [TBL] [Abstract][Full Text] [Related]
6. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis. El-Mezayen NS; El-Hadidy WF; El-Refaie WM; Shalaby TI; Khattab MM; El-Khatib AS J Control Release; 2017 Nov; 266():226-237. PubMed ID: 28965860 [TBL] [Abstract][Full Text] [Related]
7. Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo. Bansal R; Prakash J; De Ruiter M; Poelstra K J Control Release; 2014 Apr; 179():18-24. PubMed ID: 24491909 [TBL] [Abstract][Full Text] [Related]
8. Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβ. Liu F; Li S; Chen P; Gu Y; Wang S; Wang L; Chen C; Wang R; Yuan Y Int Immunopharmacol; 2023 Sep; 122():110550. PubMed ID: 37451016 [TBL] [Abstract][Full Text] [Related]
9. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling. Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890 [TBL] [Abstract][Full Text] [Related]
10. Ketogenic Diet Enhances the Cholesterol Accumulation in Liver and Augments the Severity of CCl Liao YJ; Wang YH; Wu CY; Hsu FY; Chien CY; Lee YC Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805788 [TBL] [Abstract][Full Text] [Related]
12. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis. Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888 [TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R. Yasuda Y; Shimizu M; Sakai H; Iwasa J; Kubota M; Adachi S; Osawa Y; Tsurumi H; Hara Y; Moriwaki H Chem Biol Interact; 2009 Dec; 182(2-3):159-64. PubMed ID: 19646978 [TBL] [Abstract][Full Text] [Related]
14. Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy. Omar R; Yang J; Liu H; Davies NM; Gong Y Rev Physiol Biochem Pharmacol; 2016; 172():1-37. PubMed ID: 27534415 [TBL] [Abstract][Full Text] [Related]
15. [Research progress of receptor targeted hepatic stellate cell in treatment of liver fibrosis]. Yang D Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):630-632. PubMed ID: 30317799 [TBL] [Abstract][Full Text] [Related]
16. Reversal of liver cirrhosis: current evidence and expectations. Jung YK; Yim HJ Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717 [TBL] [Abstract][Full Text] [Related]
17. Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model. Karthikeyan S; Potter JJ; Geschwind JF; Sur S; Hamilton JP; Vogelstein B; Kinzler KW; Mezey E; Ganapathy-Kanniappan S Biochem Biophys Res Commun; 2016 Jan; 469(3):463-9. PubMed ID: 26525850 [TBL] [Abstract][Full Text] [Related]
18. Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis. Krenkel O; Hundertmark J; Ritz TP; Weiskirchen R; Tacke F Cells; 2019 May; 8(5):. PubMed ID: 31137713 [TBL] [Abstract][Full Text] [Related]
19. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl He C; Shu B; Zhou Y; Zhang R; Yang X Life Sci; 2021 Jul; 276():119294. PubMed ID: 33675896 [TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]